Elaine J. Heron, Director at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 16,451 shares at $38.24 ($627K) on 2008-03-06, disclosed to the SEC on 2008-03-10.
Open-market sale of $627k BMRN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.86 | 100 | $4K | 0.6% |
| 2 | $37.90 | 100 | $4K | 0.6% |
| 3 | $37.95 | 100 | $4K | 0.6% |
| 4 | $37.96 | 100 | $4K | 0.6% |
| 5 | $38.00 | 200 | $8K | 1.2% |
| 6 | $38.01 | 300 |
| $11K |
| 1.8% |
| 7 | $38.02 | 500 | $19K | 3.0% |
| 8 | $38.03 | 700 | $27K | 4.2% |
| 9 | $38.04 | 700 | $27K | 4.2% |
| 10 | $38.05 | 700 | $27K | 4.2% |
| 11 | $38.06 | 547 | $21K | 3.3% |
| 12 | $38.07 | 1,000 | $38K | 6.1% |
| 13 | $38.08 | 1,200 | $46K | 7.3% |
| 14 | $38.09 | 800 | $30K | 4.9% |
| 15 | $38.10 | 2,100 | $80K | 12.8% |
| 16 | $38.11 | 600 | $23K | 3.6% |
| 17 | $38.12 | 800 | $30K | 4.9% |
| 18 | $38.13 | 300 | $11K | 1.8% |
| 19 | $38.14 | 900 | $34K | 5.5% |
| 20 | $38.15 | 600 | $23K | 3.7% |
| 21 | $38.16 | 1,004 | $38K | 6.1% |
| 22 | $38.17 | 300 | $11K | 1.8% |
| 23 | $38.19 | 100 | $4K | 0.6% |
| 24 | $38.20 | 400 | $15K | 2.4% |
| 25 | $38.21 | 200 | $8K | 1.2% |
| 26 | $38.22 | 300 | $11K | 1.8% |
| 27 | $38.24 | 1,000 | $38K | 6.1% |
| 28 | $38.25 | 200 | $8K | 1.2% |
| 29 | $38.26 | 200 | $8K | 1.2% |
| 30 | $38.27 | 400 | $15K | 2.4% |
| Total | $38.11 avg | 16,451 | $627K | 100% |
| Filing → |
| BMRN | SELL | 2018-09-07 | $97K | — | Filing → |
| BMRN | SELL | 2017-12-18 | $71K | — | Filing → |
| BMRN | SELL | 2012-11-13 | $91K | — | Filing → |